Please ensure Javascript is enabled for purposes of website accessibility

Gaithersburg-based Viela Bio files for $150M IPO (access required)

Viela Bio, the MedImmune spinout that has attracted more than $300 million in venture capital, filed for a $150 million initial public offering last week.

To purchase a reprint of this article, contact [email protected].